Bank of America
GLMD icon

Bank of America’s Galmed Pharmaceuticals GLMD Stock Holding History

Bank of America’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– – – 8257
2024
Q2 		– Hold
0
– – – 8294
2024
Q1 		– Hold
0
– – – 7905
2023
Q4 		– Hold
0
– – – 8071
2023
Q3 		– Hold
0
– – – 7731
2021
Q1 		– Sell
-11
Closed -$6K – 7551
2020
Q4 		$6K Buy
11
+5
+83% +$3.12K ﹤0.01% 6801
2020
Q3 		$4K Hold
6
– – ﹤0.01% 6614
2020
Q2 		$5K Hold
6
– – ﹤0.01% 6559
2020
Q1 		$3K Buy
+6
New +$5.7K ﹤0.01% 6573
2019
Q4 		– Sell
-3
Closed -$2K – 7197
2019
Q3 		$2K Sell
3
-5
-63% -$5.02K ﹤0.01% 6992
2019
Q2 		$11K Buy
8
+2
+33% +$2.58K ﹤0.01% 6704
2019
Q1 		$8K Buy
+6
New +$8.72K ﹤0.01% 6705
2018
Q4 		– Sell
-1
Closed -$1K – 7196
2018
Q3 		$1K Buy
+1
New +$2.34K ﹤0.01% 7119
2017
Q1 		– Sell
-3
Closed -$2K – 7063
2016
Q4 		$2K Hold
3
– – ﹤0.01% 6841
2016
Q3 		$2K Hold
3
– – ﹤0.01% 6819
2016
Q2 		$2K Hold
3
– – ﹤0.01% 6895
2016
Q1 		$2K Hold
3
– – ﹤0.01% 6773
2015
Q4 		$4K Hold
3
– – ﹤0.01% 6942
2015
Q3 		$3K Hold
3
– – ﹤0.01% 6887
2015
Q2 		$5K Hold
3
– – ﹤0.01% 6809
2015
Q1 		$4K Hold
3
– – ﹤0.01% 6558
2014
Q4 		$3K Hold
3
– – ﹤0.01% 7396
2014
Q3 		$4K Buy
+3
New +$4.1K ﹤0.01% 7605

Other funds holding GLMD

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return

Bank of America's GLMD Position: Q3 2024 in Review

Bank of America held its Galmed Pharmaceuticals (GLMD) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8257.

Bank of America first reported a position in GLMD in Q3 2014 and has held it in 18 quarters since. The position peaked at $11K in Q2 2019. 10 funds tracked by Wall St. Rank hold GLMD as of Q3 2024.

  • Bank of America held 0 shares of Galmed Pharmaceuticals worth $0 as of Q3 2024.
  • Bank of America left its Galmed Pharmaceuticals share count unchanged in Q3 2024.
  • Galmed Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q3 2024, its #8257 holding.
  • Bank of America first reported a position in Galmed Pharmaceuticals in Q3 2014 and has held it in 18 quarters since.
  • Bank of America's Galmed Pharmaceuticals position peaked at $11K in Q2 2019.
  • 10 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.